Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis.
Atypical chronic lymphocytic leukemia
ibrutinib
leukocytosis
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
17
09
2019
revised:
09
01
2020
accepted:
06
02
2020
entrez:
2
6
2020
pubmed:
2
6
2020
medline:
2
6
2020
Statut:
epublish
Résumé
Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B-cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in higher risk CLL subgroups.
Identifiants
pubmed: 32477538
doi: 10.1002/ccr3.2773
pii: CCR32773
pmc: PMC7250984
doi:
Types de publication
Case Reports
Langues
eng
Pagination
877-882Informations de copyright
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Leuk Res. 2013 Oct;37(10):1271-7
pubmed: 23962569
Clin Adv Hematol Oncol. 2009 Apr;7(4):263-71
pubmed: 19521331
Folia Med (Plovdiv). 2000;42(3):5-10
pubmed: 11347338
Hematology Am Soc Hematol Educ Program. 2012;2012:475-84
pubmed: 23233622
Medicina (B Aires). 2005;65(5):419-24
pubmed: 16296638
Br J Haematol. 2010 May;149(4):578-86
pubmed: 20331465
Blood. 2014 Mar 20;123(12):1772-4
pubmed: 24652958
Curr Hematol Malig Rep. 2011 Mar;6(1):36-46
pubmed: 21153774
Am J Clin Pathol. 2001 Nov;116(5):655-64
pubmed: 11710681
N Engl J Med. 2018 Dec 27;379(26):2517-2528
pubmed: 30501481
Arch Pathol Lab Med. 2018 Oct;142(10):1268-1274
pubmed: 29869903
Leuk Lymphoma. 2016;57(4):766-82
pubmed: 26592922
Aust Prescr. 2015 Oct;38(5):178-80
pubmed: 26648658
Br J Haematol. 1995 Jun;90(2):409-16
pubmed: 7794764
Mod Pathol. 2002 Nov;15(11):1111-20
pubmed: 12429788
Cancer Res. 1997 Mar 15;57(6):1144-50
pubmed: 9067285
Leuk Lymphoma. 2017 Dec;58(12):2777-2785
pubmed: 28509580
Lancet Oncol. 2016 Oct;17(10):1409-1418
pubmed: 27637985
J Cell Physiol. 2009 Aug;220(2):292-6
pubmed: 19415697
Mol Clin Oncol. 2016 May;4(5):682-694
pubmed: 27123263
Int J Nephrol. 2011;2011:759749
pubmed: 21603111
P T. 2014 Jul;39(7):483-519
pubmed: 25083126
Haematologica. 2019 May;104(5):e211-e214
pubmed: 30442728